Benitec Biopharma (BNTC) Institutional Ownership $14.67 +0.33 (+2.30%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)CurrentInstitutional OwnershipPercentage52.19%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$144.11MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.49M Get BNTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNTC Institutional Buying and Selling by Quarter Remove Ads Benitec Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/26/2025 Infinitum Asset Management LLC210,000$2.65M1.4%N/A0.895% 2/18/2025 AWM Investment Company Inc.102,027$1.29M0.2%-83.7%0.439% 2/17/2025 Suvretta Capital Management LLC8,960,009$113.17M3.9%+1.5%38.587% 2/17/2025 Lion Point Capital LP62,000$783K4.1%+59.0%0.267% 2/17/2025 Janus Henderson Group PLC2,616,427$33.27M0.0%+198.5%11.268% 2/17/2025 Ameriprise Financial Inc.35,476$448K0.0%+138.4%0.153% 2/17/2025 683 Capital Management LLC35,817$452K0.0%N/A0.154% 2/14/2025 Schonfeld Strategic Advisors LLC260,417$3.29M0.0%-4.5%1.122% 2/14/2025 Northern Trust Corp38,200$482K0.0%+54.2%0.165% 2/14/2025 Adage Capital Partners GP L.L.C.1,972,524$24.91M0.0%+134.4%8.495% Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 MYDA Advisors LLC50,000$632K0.2%N/A0.215% 2/12/2025 Geode Capital Management LLC197,096$2.49M0.0%+134.7%0.849% 2/12/2025 Franklin Resources Inc.2,939,287$37.12M0.0%+269.0%12.658% 2/11/2025 Simplify Asset Management Inc.76,337$964K0.0%-34.5%0.329% 11/16/2024 Geode Capital Management LLC83,987$772K0.0%+31.3%0.795% 11/15/2024 Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300% 11/14/2024 Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640% 11/14/2024 Acuta Capital Partners LLC29,800$274K0.2%N/A0.282% 11/6/2024 Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104% 10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070% 8/20/2024 Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982% 8/13/2024 Simplify Asset Management Inc.51,216$358K0.0%N/A0.547% 7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058% 5/16/2024 Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440% 11/15/2023 Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419% 11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848% 11/15/2022 Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478% 11/14/2022 Armistice Capital LLC1,555,039$578K0.0%N/A6.025% 11/14/2022 Altium Capital Management LP658,796$245K0.1%N/A2.552% 11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244% 8/16/2021 State Street Corp21,000$89K0.0%N/A0.267% 8/13/2021 Renaissance Technologies LLC42,700$181K0.0%N/A0.544% 8/13/2021 Northern Trust Corp11,813$50K0.0%N/A0.150% 8/13/2021 Geode Capital Management LLC34,493$146K0.0%+20.8%0.439% 8/13/2021 Vanguard Group Inc.74,773$318K0.0%+43.3%0.952% 8/11/2021 Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190% 7/31/2021 Private Wealth Advisors LLC15,043$64K0.0%N/A0.192% 5/21/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/19/2021 Virtu Financial LLC22,520$116K0.0%+17.8%0.467% 5/18/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483% 30-year market phenomenon opens up overnight opportunity (Ad)Imagine this: When things worked out, you woke up, checked your account, and saw that you’ve made money overnight. Sounds like a dream, right? Well, what if that wasn’t a dream anymore? Earning while you sleep isn’t easy, and it definitely doesn’t happen overnight for most people. Tap here for the full breakdown.5/13/2021 Bank of New York Mellon Corp17,653$91K0.0%N/A0.366% 5/12/2021 Geode Capital Management LLC28,560$147K0.0%N/A0.593% 4/14/2021 WealthTrust Axiom LLC12,950$66K0.0%N/A0.269% 4/12/2021 HighPoint Advisor Group LLC93,000$462K0.1%N/A1.930% 3/4/2021 Hudson Bay Capital Management LP107,995$324K0.0%N/A2.241% 2/24/2021 Virtu Financial LLC19,114$57K0.0%N/A0.397% 2/16/2021 Warberg Asset Management LLC10,000$30K0.0%N/A0.903% 2/10/2021 Renaissance Technologies LLC50,660$152K0.0%N/A4.572% (Data available from 1/1/2016 forward)Remove Ads BNTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNTC shares? During the previous two years, 17 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Suvretta Capital Management LLC ($113.17M), Franklin Resources Inc. ($37.12M), Janus Henderson Group PLC ($33.27M), Adage Capital Partners GP L.L.C. ($24.91M), Nantahala Capital Management LLC ($5.88M), Schonfeld Strategic Advisors LLC ($3.29M), and Infinitum Asset Management LLC ($2.65M).Learn more on BNTC's institutional investors. What percentage of Benitec Biopharma stock is owned by institutional investors? 52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings. Which institutional investors have been buying Benitec Biopharma stock? Of the 15 institutional investors that purchased Benitec Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($7.27M), Franklin Resources Inc. ($2.14M), Janus Henderson Group PLC ($1.80M), Adage Capital Partners GP L.L.C. ($1.32M), Nantahala Capital Management LLC ($841.40K), Infinitum Asset Management LLC ($210K), and Geode Capital Management LLC ($133.12K). How much institutional buying is happening at Benitec Biopharma? Institutional investors have bought a total of 14,012,351 shares in the last 24 months. This purchase volume represents approximately $144.69M in transactions. Which Benitec Biopharma major shareholders have been selling company stock? The following institutional investors have sold Benitec Biopharma stock in the last 24 months: AWM Investment Company Inc. ($522.97K), Simplify Asset Management Inc. ($40.20K), Janus Henderson Group PLC ($24.29K), and Schonfeld Strategic Advisors LLC ($12.40K). How much institutional selling is happening at Benitec Biopharma? Institutional investors have sold a total of 599,864 shares in the last 24 months. This volume of shares sold represents approximately $7.49M in transactions. Related Companies ETNB Major Shareholders ADPT Major Shareholders EVO Major Shareholders SPRY Major Shareholders ARDX Major Shareholders OCUL Major Shareholders GPCR Major Shareholders CALT Major Shareholders IOVA Major Shareholders SNDX Major Shareholders This page (NASDAQ:BNTC) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNTC Stock Free BNTC Stock Alerts